Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June

May 28, 2024

https://www.globenewswire.com/news-release/2024/05/28/2888873/0/en/Foghorn-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences-in-June.html

CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq:FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced management’s participation in the Jefferies Global Healthcare Conference and the Goldman Sachs 45th Annual Global Healthcare Conference. With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.